The device was discarded by the user facility and is not available for evaluation.The device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling.The relationship between the event and the device is unknown.Capsular bag damage and vitreous loss are inherent risks of cataract surgery.Manufacturer's reference #: (b)(4).
|
A (b)(6) female patient underwent cataract surgery in her right eye on (b)(6) 2019 where the miloop device was used to section the cataractous lens into quadrants.The case appeared typical through phacoemulsification, including the first lens sectioning, lens rotation with a drysdale nucleus manipulator (storz), and the second lens sectioning.After sectioning the second lens quadrant, a small capsular tear was observed when the miloop was removed from the eye.After phacoemulsification, a posterior capsular tear occurred parallel to the primary incision.Although the degree of vitreous loss was limited, an anterior vitrectomy was performed and a sulcus-fixated intraocular lens was implanted.The patient was reported as doing well at the one day postoperative visit.At the one week visit, there was some residual corneal edema and the patient's best corrected visual acuity (bcva) was 20/30 (no baseline provided); the patient reports feeling fine and happy.
|